Tuesday 22 January 2019
Home      All news      Contact us     
cnbc.com - 9 month ago

Currency and pricing squeeze GlaxoSmithKline as new shingles vaccine shines

GlaxoSmithKline s new shingles vaccine Shingrix exceeded expectations in the first quarter, but the drugmaker s sales and earnings fell 2 percent, held back by a stronger pound and more pricing pressure in respiratory medicine.

Related news

Latest News
Hashtags:   

Currency

 | 

pricing

 | 

squeeze

 | 

GlaxoSmithKline

 | 

shingles

 | 

vaccine

 | 

shines

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources